LC/MS, LC/MS/MS, LC/QQQ
IndustriesClinical Research
ManufacturerAgilent Technologies
Significance of the Topic
Secondary bile acids are abundant microbiota-derived metabolites that influence host physiology and serve as biomarkers for metabolic and gastrointestinal diseases.
Study Objectives and Overview
This work aimed to develop a targeted LC-MS/MS assay for 26 bile acids with enhanced selectivity, robustness, and minimal sample preparation, replacing traditional GC-MS approaches.
Instrumentation
- UHPLC: Agilent 1290 Infinity II with Poroshell EC-C18 (2.1×150 mm, 2.7 μm) at 45 °C
- Mass Spectrometer: Agilent 6470 Triple Quadrupole with Jet Stream ESI, positive/negative polarity switching, dynamic MRM
Methodology
- Optimized 110 MRM transitions using MassHunter Optimizer
- Mobile phases: A = 0.1% formic acid + 20 mM ammonium acetate in water; B = 0.1% formic acid in acetone
- Gradient: 32% B for 6 min, ramp to 65% at 25 min, up to 98% at 25.1 min, total runtime 32.1 min
- Sample preparation: methanol extraction and protein precipitation of plasma, methanol/water extraction of fecal samples
Key Results and Discussion
- Baseline separation achieved for 24 of 26 bile acid isomers; improved lipid elution with acetone mobile phase
- LLOQs ranged from 0.5 to 20 nM with calibration R² > 0.99 over 4.3 orders of magnitude
- Robust performance over 200 injections with retention time CV < 0.15% and area CV ≈ 2.7%
- Application to conventional and gnotobiotic mouse fecal extracts revealed drastically reduced secondary bile acid levels in germ-free animals
Benefits and Practical Applications
- Enhanced selectivity and sensitivity in complex biological matrices
- Minimal sample cleanup and reduced lipid carryover
- High throughput profiling suitable for microbiome and clinical studies
- Facilitates pathway mapping of bile acid metabolism using software tools
Future Trends and Applications
Integration with high-resolution metabolomics platforms, discovery of novel microbial metabolites, real-time clinical monitoring, and automation of sample preparation and data analysis.
Conclusion
The refined LC-MS/MS workflow provides a robust, sensitive, and high-throughput platform for comprehensive bile acid analysis, supporting advanced microbiome research and biomarker discovery.
References
1. Devlin AS, Fischbach MA. Nature Chem Biol. 2015;11(9):685-90
2. Wegner K et al. Anal Bioanal Chem. 2017;409(5):1231-45
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.